These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27888350)

  • 41. Technique for placement of a totally implantable venous access device.
    Kondi ES; Pietrafitta JJ; Barriola JA
    J Surg Oncol; 1988 Apr; 37(4):272-7. PubMed ID: 3361920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An inferolateral approach to nipple-sparing mastectomy: optimizing mastectomy and reconstruction.
    Colwell AS; Gadd M; Smith BL; Austen WG
    Ann Plast Surg; 2010 Aug; 65(2):140-3. PubMed ID: 20606592
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ultrasound-assisted percutaneous catheterization of the axillary vein for totally implantable venous access device.
    Lin CP; Wang YC; Lin FS; Huang CH; Sun WZ
    Eur J Surg Oncol; 2011 May; 37(5):448-51. PubMed ID: 21345637
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A technique for minimising the redundant skin of a mastectomy scar and improving cosmesis for delayed reconstruction.
    Tuffaha H; Hussien M
    Ann R Coll Surg Engl; 2017 Mar; 99(3):252-253. PubMed ID: 27917661
    [No Abstract]   [Full Text] [Related]  

  • 45. Update on totally implantable venous access devices.
    Zaghal A; Khalife M; Mukherji D; El Majzoub N; Shamseddine A; Hoballah J; Marangoni G; Faraj W
    Surg Oncol; 2012 Sep; 21(3):207-15. PubMed ID: 22425356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is there any effect of first-day usage of a totally implantable venous access device on complications?
    Karanlik H; Odabas H; Yildirim I; Ozgur I; Kilic B; Sen F; Kurul S; Aydiner A
    Int J Clin Oncol; 2015 Dec; 20(6):1057-62. PubMed ID: 25911604
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications.
    Di Carlo I; Pulvirenti E; Mannino M; Toro A
    Ann Surg Oncol; 2010 Jun; 17(6):1649-56. PubMed ID: 20204533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term outcomes of totally implantable venous access devices.
    Wang YC; Lin PL; Chou WH; Lin CP; Huang CH
    Support Care Cancer; 2017 Jul; 25(7):2049-2054. PubMed ID: 28181014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Totally implantable venous access device inserted during major abdominal operations for cancer. A new technique.
    Di Carlo I; Lombardo R; Russello D; Puleo S
    Hepatogastroenterology; 2000; 47(34):907-8. PubMed ID: 11020844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Totally implanted ports: the trapezius approach in practice.
    Hill S
    Br J Nurs; 2015 Oct 22-Nov 11; 24(19):S22-6. PubMed ID: 26496871
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subpectoral breast reconstruction using the biodimensional system.
    Hayes AJ; Jenkins MP; Sandhu SS; Baum M
    Ann R Coll Surg Engl; 1997 Sep; 79(5):355-60. PubMed ID: 9326128
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modification of approach for totally implantable venous access device decreases rate of complications.
    Karanlik H; Kurul S
    J Surg Oncol; 2009 Sep; 100(3):279-83. PubMed ID: 19582820
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of prolonged flushing interval in totally implantable venous access devices (TIVADs).
    Rasero L; Golin L; Ditta S; Di Massimo DS; Dal Molin A; Piemonte G
    Br J Nurs; 2018 Apr; 27(8):S4-S10. PubMed ID: 29683741
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implanted vascular access device options: a focused review on safety and outcomes.
    Blanco-Guzman MO
    Transfusion; 2018 Feb; 58 Suppl 1():558-568. PubMed ID: 29443407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypnosis as adjunct therapy to conscious sedation for venous access device implantation in breast cancer: A pilot study.
    Sterkers N; Chabrol JL; De Troyer J; Bonijol D; Darmon JC; Donnez O
    J Vasc Access; 2018 Jul; 19(4):382-386. PubMed ID: 29566587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Infection of totally implantable venous access devices: A review of the literature.
    Pinelli F; Cecero E; Degl'Innocenti D; Selmi V; Giua R; Villa G; Chelazzi C; Romagnoli S; Pittiruti M
    J Vasc Access; 2018 May; 19(3):230-242. PubMed ID: 29512430
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Prospective, Comparative Evaluation on Totally Implantable Venous Access Devices by External Jugular Vein
    Iorio O; Gazzanelli S; D'Ermo G; Pezzolla A; Gurrado A; Testini M; De Toma G; Cavallaro G
    Am Surg; 2018 Jun; 84(6):841-843. PubMed ID: 29981612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Feasibility and safety of endovascular stripping of totally implantable venous access devices.
    Heye S; Maleux G; Goossens GA; Vaninbroukx J; Jerôme M; Stas M
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):607-12. PubMed ID: 21479744
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A peripherally implanted permanent central venous access device.
    Morris P; Buller R; Kendall S; Anderson B
    Obstet Gynecol; 1991 Dec; 78(6):1138-42. PubMed ID: 1945224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of three different techniques for insertion of totally implantable venous access device: A randomized clinical trial.
    Tagliari AP; Staub FL; Guimarães JR; Migliavacca A; Mossmann Dda F
    J Surg Oncol; 2015 Jul; 112(1):56-9. PubMed ID: 26175279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.